Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Acute urinary retention: risks and management.

Roehrborn CG.

Rev Urol. 2005;7 Suppl 4:S31-41.

2.

Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.

Logan YT, Belgeri MT.

Am J Geriatr Pharmacother. 2005 Jun;3(2):103-14. Review.

PMID:
16129387
3.

Definition of at-risk patients: dynamic variables.

Emberton M.

BJU Int. 2006 Apr;97 Suppl 2:12-5; discussion 21-2. Review.

5.
6.

The natural history of benign prostatic hyperplasia.

Fitzpatrick JM.

BJU Int. 2006 Apr;97 Suppl 2:3-6; discussion 21-2. Review.

7.
8.

Long-term aspects of medical treatment of BPH.

Schulman CC.

Eur Urol. 2001;40 Suppl 3:8-12. Review.

PMID:
11786671
9.
10.

Definition of at-risk patients: baseline variables.

Roehrborn CG.

BJU Int. 2006 Apr;97 Suppl 2:7-11; discussion 21-2. Review.

11.

A review of combination therapy in patients with benign prostatic hyperplasia.

McVary KT.

Clin Ther. 2007 Mar;29(3):387-98. Review.

PMID:
17577460
12.

Acute urinary retention: medical management and the identification of risk factors for prevention.

Khastgir J, Khan A, Speakman M.

Nat Clin Pract Urol. 2007 Aug;4(8):422-31. Review.

PMID:
17673913
13.

Benign prostatic hyperplasia progression and its impact on treatment.

Djavan B, Waldert M, Ghawidel C, Marberger M.

Curr Opin Urol. 2004 Jan;14(1):45-50. Review.

PMID:
15091050
14.

The Reten-World survey of the management of acute urinary retention: preliminary results.

Emberton M, Fitzpatrick JM.

BJU Int. 2008 Mar;101 Suppl 3:27-32. doi: 10.1111/j.1464-410X.2008.07491.x. Review.

15.

Prevention of benign prostatic hyperplasia disease.

Marks LS, Roehrborn CG, Andriole GL.

J Urol. 2006 Oct;176(4 Pt 1):1299-306. Review.

PMID:
16952616
18.

BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE.

Roehrborn CG.

BJU Int. 2008 Mar;101 Suppl 3:17-21. doi: 10.1111/j.1464-410X.2008.07497.x. Review.

20.

Watchful waiting in benign prostatic hyperplasia.

Wiygul J, Babayan RK.

Curr Opin Urol. 2009 Jan;19(1):3-6. doi: 10.1097/MOU.0b013e32831a6ec6. Review.

PMID:
19057209
Items per page

Supplemental Content

Support Center